Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha; Katarzyna Krawczyk;
Hematol Transfus Cell Ther. 2025;47:
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes; Breno Moreno de Gusmão; Franciely Bueno Wiginesk; Euler Manenti; Juliana Soares; Mizianne Garcia Freitas; Juliane Dantas Seabra-Garcez; Alexandre Manoel Varela; João Pedro Passos Dutra; Bruno Cesar Bacchiega; Tânia Félix Lorenzato da Fonseca Peixoto; Carolina Maria Pinto Domingues de Carvalho e Silva; Renato D. Lopes; Ariane Vieira Scarlatelli Macedo;
Hematol Transfus Cell Ther. 2025;47:
Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience
Heloísa Maria Farias Fontes; Júlia Peres de Freitas; José Henrique Vanderlei Oliveira; Édyla Almeida de Sousa Moraes; Eduardo Magalhães Rego; Raul Antônio Morais Melo;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S122-8